A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Clinical trial NCT02393937 · COMPLETED

Trial details

NCT number: NCT02393937
Sponsor: bioRASI, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Papulopustular Rosacea Erythematotelangiectatic Rosacea

Start date: 2015-02-01
Primary completion: 2015-07-01
Enrollment: 963

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.